📊 CORZR Key Takeaways
Investment Thesis
Core Scientific exhibits severe financial distress with negative stockholders' equity of -$962.7M, indicating liabilities exceed assets and shareholder value has been destroyed. The company burns through capital with negative free cash flow of -$450.8M despite generating $278.2M in operating cash flow, driven by unsustainable capital expenditures of $729M. Revenue declined 37.5% YoY while net losses widened to -$288.6M, demonstrating deteriorating operational performance across all profitability metrics.
CORZR Strengths
- Operating cash flow of $278.2M provides near-term liquidity buffer
- Current ratio of 1.15x indicates ability to cover short-term obligations
- Cash position of $311.4M offers runway for operations
CORZR Risks
- Negative stockholders' equity of -$962.7M indicates potential insolvency; liabilities ($3.3B) far exceed assets ($2.3B)
- Massive negative free cash flow of -$450.8M is unsustainable; company burning $1.41 in cash for every dollar of revenue
- Revenue collapsed 37.5% YoY while operating losses expanded to -$245.6M, indicating operational model failure and deteriorating unit economics
- Capital expenditure of $729M is grossly disproportionate to revenue base, suggesting failed growth investments or impaired asset valuations
- Net margin of -90.5% and operating margin of -77.0% demonstrate fundamental business model dysfunction
Key Metrics to Watch
- Operating cash flow trajectory and sustainability of $278.2M burn rate
- Cash depletion rate given negative FCF and current cash position of $311.4M
- Revenue stabilization and margin recovery toward positive operating income
- Capital expenditure reduction and asset utilization efficiency
- Debt restructuring or recapitalization necessity given negative equity position
CORZR Financial Metrics
💡 AI Analyst Insight
Core Scientific, Inc./tx presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
CORZR Profitability Ratios
CORZR vs Finance Sector
How Core Scientific, Inc./tx compares to Finance sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CORZR Balance Sheet & Liquidity
CORZR 5-Year Financial Trend
5-Year Trend Summary: Core Scientific, Inc./tx's revenue has declined by 20% over the 5-year period, indicating business contraction. The most recent EPS of $-0.65 indicates the company is currently unprofitable.
CORZR Growth Metrics (YoY)
CORZR Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $81.1M | -$146.7M | $-0.46 |
| Q2 2025 | $78.6M | -$356.1M | $-0.04 |
| Q1 2025 | $79.5M | $210.7M | $0.78 |
| Q3 2024 | $95.4M | -$41.1M | $-0.11 |
| Q2 2024 | $126.9M | -$9.3M | $-0.02 |
| Q1 2024 | $120.7M | -$388.0K | $0.00 |
| Q3 2023 | $112.9M | -$388.0K | $0.00 |
| Q2 2023 | $126.9M | -$388.0K | $0.00 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CORZR Capital Allocation
CORZR SEC Filings
Access official SEC EDGAR filings for Core Scientific, Inc./tx (CIK: 0001839341)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CORZR
What is the AI rating for CORZR?
Core Scientific, Inc./tx (CORZR) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CORZR's key strengths?
Operating cash flow of $278.2M provides near-term liquidity buffer. Current ratio of 1.15x indicates ability to cover short-term obligations.
What are the risks of investing in CORZR?
Negative stockholders' equity of -$962.7M indicates potential insolvency; liabilities ($3.3B) far exceed assets ($2.3B). Massive negative free cash flow of -$450.8M is unsustainable; company burning $1.41 in cash for every dollar of revenue.
What is CORZR's revenue and growth?
Core Scientific, Inc./tx reported revenue of $319.0M.
Does CORZR pay dividends?
Core Scientific, Inc./tx does not currently pay dividends.
Where can I find CORZR SEC filings?
Official SEC filings for Core Scientific, Inc./tx (CIK: 0001839341) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CORZR's EPS?
Core Scientific, Inc./tx has a diluted EPS of $-0.88.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.